A Phase 3 Study of Orelabrutinib to Delay Disability Progression in Patients with Non‑Active Secondary Progressive Multiple Sclerosis
- Substances:–
Slovenia- Participants:18–64 years
- Sponsor:Zenas Biopharma (USA) LLC
Rare diseases
Investigational molecules
Locations
Back to Slovenia95 clinical trials in Ljubljana, Slovenia across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SloveniaKlinicnaPreskusanja.si(opens in a new tab)
SloveniaA Study Comparing Empasiprubart Versus Intravenous Immunoglobulin in Adults With Chronic Inflammatory Demyelinating Polyneuropathy
SloveniaA study to evaluate the safety of dazodalibep in patients with Sjögren's Syndrome over a long period of time
SloveniaA Study of Darovasertib Before Surgery or Radiation Therapy for Patients with Early-Stage Uveal Melanoma That Has Not Spread
SloveniaStudy on BI 690517 and Empagliflozin for Patients with Heart Failure and Preserved Ejection Fraction
SloveniaStudy of belumosudil versus drug combination in patients aged 12 years and older with chronic graft‑versus‑host disease refractory after prior therapy
SloveniaLong‑Term Safety Follow‑up of Ornithine Transcarbamylase Deficiency Patients Treated with ECUR‑506D and ECUR‑506A
SloveniaA study to evaluate the effectiveness of bleomycin sulfate for treating patients with low-flow vascular malformations using electrosclerotherapy.
SloveniaA study to evaluate the effectiveness and safety of remibrutinib in patients with secondary progressive multiple sclerosis
SloveniaA study to test if empasiprubart can improve function and is safe for adults with chronic inflammatory demyelinating polyneuropathy
Slovenia
SloveniaA Study of Puxitatug Samrotecan Compared to Chemotherapy for Patients with Advanced Endometrial Cancer After Previous Platinum and Immunotherapy Treatment
SloveniaThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on Sjögren's Syndrome and inflammatory bowel conditions, including studies evaluating novel therapeutic approaches for Crohn's Disease and Ulcerative Colitis.
Multiple studies investigating long-term effectiveness and patient outcomes in chronic inflammatory conditions.
Comprehensive studies addressing cardiovascular disease and related conditions, including research on lipoprotein management and cardiac inflammation treatments.
Focus on preventive measures and innovative therapeutic approaches for various cardiac conditions.
Advanced research in cancer treatment, including studies on breast cancer, melanoma, and various blood cancers.
Emphasis on personalized treatment approaches and improved patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.